Borovcanin et al. investigated serum level of IL-33 and sST2 in different stages of schizophrenia [29]; 167 participants were evaluated: 77 drug naïve patients with first episode psychosis (FEP), 45 relapsed schizophrenia patients with acute symptoms, 27 remitted schizophrenia patients, and 18 HC. The gene discussed is IL33; the disease is schizophrenia.